Summary
- Current Price
- As of today, NRSN price is $0.82, up +0.84% on
- Current Price All-Time High
- NRSN price is currently -90.00% below its historical high of $8.18 set on
- Market Cap
- NRSN current market cap is $24M, down -11.07% year-over-year
- PE Ratio
- NRSN PE ratio is unknown
- Revenue
- NRSN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for NRSN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | NeuroSense Therapeutics Ltd. |
| Ticker | NASDAQ: NRSN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | neurosense-tx.com |
| Employees | 17 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.82 | ||
| Price, 1D Change | +0.84% | |
| $24M | ||
| - | ||
| - | ||
| 0.44 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.55 | ||
| EPS, 1Y Change | +25.92% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.55 | ||
| EPS Estimate | N/A | -$0.40 |
| EPS Est. Change | N/A | +27.13% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.82 | ||
| Price Target | - | $8.25 |
| Price Tgt. Change | - | +908.56% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.85 | -$0.74 | +12.82% | |
| -$0.55 | -$0.55 | +0.20% | |
| -$0.40 | N/A | +27.13% | |
| -$0.18 | N/A | +67.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $714.00K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -30.44% | ||
| -54.81% | ||
| -11.07% | ||
| +13.83% | ||
| 0.00% | ||
| 0.00% | ||
| +25.92% | ||
| +73.63% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.82 | ||
| $1.26 | ||
| SMA 200 vs Price | +53.74% | |
| $0.92 | ||
| SMA 50 vs Price | +12.84% | |
| 0.44 | ||
| $0.08 | ||
| 41.55 | ||
| 53.00% | ||
| 94.59% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.55 | ||
| -$22.00K | ||
| - | ||
| -$9.90M | ||
| - | ||
| -$10.21M | ||
| - | ||
| -$9.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 2.21 | ||
| 2.21 | ||
| - | ||
| - | ||
| -10.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -46.81 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $2.58M | ||
| $3.38M | ||
| $4.58M | ||
| $4.40M | ||
| $1.99M | ||
| $1.99M | ||
| $73.00K | ||
| $73.00K | ||
| $1.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $9.90M | ||
| $9.90M | ||
| $22.00K | ||
| $4.20M | ||
| $22.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$10.14M | ||
| $1,000.00 | ||
| $10.91M | ||
| $3,000.00 | ||
| -$10.14M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth Capital | ||
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | ||
| Maxim Group | → |
Analyst sentiment
Institutional ownership
Screeners with NRSN
FAQ
What is the ticker symbol for NeuroSense Therapeutics Ltd.?
The ticker symbol for NeuroSense Therapeutics Ltd. is NASDAQ:NRSN
Does NeuroSense Therapeutics Ltd. pay dividends?
No, NeuroSense Therapeutics Ltd. does not pay dividends
What sector is NeuroSense Therapeutics Ltd. in?
NeuroSense Therapeutics Ltd. is in the Healthcare sector
What industry is NeuroSense Therapeutics Ltd. in?
NeuroSense Therapeutics Ltd. is in the Biotechnology industry
What country is NeuroSense Therapeutics Ltd. based in?
NeuroSense Therapeutics Ltd. is headquartered in Israel
When did NeuroSense Therapeutics Ltd. go public?
NeuroSense Therapeutics Ltd. initial public offering (IPO) was on December 9, 2021
Is NeuroSense Therapeutics Ltd. in the S&P 500?
No, NeuroSense Therapeutics Ltd. is not included in the S&P 500 index
Is NeuroSense Therapeutics Ltd. in the NASDAQ 100?
No, NeuroSense Therapeutics Ltd. is not included in the NASDAQ 100 index
Is NeuroSense Therapeutics Ltd. in the Dow Jones?
No, NeuroSense Therapeutics Ltd. is not included in the Dow Jones index
When was NeuroSense Therapeutics Ltd. last earnings report?
NeuroSense Therapeutics Ltd.'s most recent earnings report was on March 22, 2023
When does NeuroSense Therapeutics Ltd. report earnings?
The date for NeuroSense Therapeutics Ltd.'s next earnings report has not been announced yet
Data Sources & References
- NRSN Official Website www.neurosense-tx.com
- NRSN Profile on Yahoo Finance finance.yahoo.com/quote/NRSN
- NRSN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nrsn